Effects of a lifestyle intervention programme after 1 year of follow-up among South Asians at high risk of type 2 diabetes: a cluster randomised controlled trial.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
11 2021
Historique:
received: 01 06 2021
accepted: 30 09 2021
entrez: 2 11 2021
pubmed: 3 11 2021
medline: 15 12 2021
Statut: ppublish

Résumé

South Asians are at high risk of type 2 diabetes (T2D). We assessed whether intensive family-based lifestyle intervention leads to significant weight loss, improved glycaemia and blood pressure in adults at elevated risk for T2D. This cluster randomised controlled trial (iHealth-T2D) was conducted at 120 locations across India, Pakistan, Sri Lanka and the UK. We included 3684 South Asian men and women, aged 40-70 years, without T2D but with raised haemoglobin A1c (HbA1c) and/or waist circumference. Participants were randomly allocated either to the family-based lifestyle intervention or control group by location clusters. Participants in the intervention received 9 visits and 13 telephone contacts by community health workers over 1-year period, and the control group received usual care. Reductions in weight (aim >7% reduction), waist circumference (aim ≥5 cm reduction), blood pressure and HbA1C at 12 months of follow-up were assessed. Our linear mixed-effects regression analysis was based on intention-to-treat principle and adjusted for age, sex and baseline values. There were 1846 participants in the control and 1838 in the intervention group. Between baseline and 12 months, mean weight of participants in the intervention group reduced by 1.8 kg compared with 0.4 kg in the control group (adjusted mean difference -1.10 kg (95% CI -1.70 to -1.06), p<0.001). The adjusted mean difference for waist circumference was -1.9 cm (95% CI -2.5; to 1.3), p<0.001). No overall difference was observed for blood pressure or HbA1c. People who attended multiple intervention sessions had a dose-dependent effect on waist circumference, blood pressure and HbA1c, but not on weight. An intensive family-based lifestyle intervention adopting low-resource strategies led to effective reduction in weight and waist circumference at 12 months, which has potential long-term benefits for preventing T2D. A higher number of attended sessions increased the effect on waist circumference, blood pressure and HbA1c. EudraCT: 2016-001350-18; ClinicalTrials.gov: NCT02949739.

Identifiants

pubmed: 34725039
pii: bmjgh-2021-006479
doi: 10.1136/bmjgh-2021-006479
pmc: PMC8562508
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02949739']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Behav Nutr Phys Act. 2015 Jan 24;12:4
pubmed: 25616598
BMC Med Res Methodol. 2002 Jun 17;2:8
pubmed: 12069695
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
Diabetologia. 2006 Feb;49(2):289-97
pubmed: 16391903
PLoS One. 2015 Sep 14;10(9):e0137739
pubmed: 26368020
Diabetes Care. 2016 Nov;39(11):2065-2079
pubmed: 27926890
Diabetes Care. 2016 Oct;39(10):1760-7
pubmed: 27504014
JAMA Intern Med. 2021 Feb 1;181(2):168-178
pubmed: 33136119
Diabetes Care. 2003 Dec;26(12):3230-6
pubmed: 14633807
Diabetes Care. 2014 Sep;37(9):2500-7
pubmed: 24974975
Diabetes Care. 2007 Dec;30(12):3116-8
pubmed: 17804678
Diabetologia. 2009 Jun;52(6):1019-26
pubmed: 19277602
Intern Emerg Med. 2016 Apr;11(3):327-40
pubmed: 26370238
PLoS One. 2017 Jul 13;12(7):e0180640
pubmed: 28704405
Perspect Clin Res. 2011 Jul;2(3):109-12
pubmed: 21897887
PLoS Med. 2018 Jun 6;15(6):e1002575
pubmed: 29874236
JAMA Intern Med. 2017 Dec 1;177(12):1808-1817
pubmed: 29114778
Trials. 2021 Dec 18;22(1):928
pubmed: 34922608
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
Diabetologia. 2019 Aug;62(8):1337-1348
pubmed: 31201437
Stat Methods Med Res. 2018 Sep;27(9):2610-2626
pubmed: 28034175
Diabetes Care. 2011 May;34 Suppl 2:S184-90
pubmed: 21525453
Diabetes Care. 2007 Jun;30(6):1647-52
pubmed: 17360974
Ann N Y Acad Sci. 2013 Apr;1281:51-63
pubmed: 23317344
Diabet Med. 2013 Jan;30(1):26-34
pubmed: 22827704

Auteurs

Mirthe Muilwijk (M)

Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands m.muilwijk@amsterdamumc.nl.

Marie Loh (M)

Lee Kon Chian School of Medicine, Nanyang Technological University, Singapore.
Department of Epidemiology and Biostatistics, Imperial College London, London, UK.

Samreen Siddiqui (S)

Institute of Endocrinology Diabetes and Metabolism, Max Healthcare, New Delhi, Delhi, India.

Sara Mahmood (S)

Department of Endocrinology & Metabolism, Services Institute of Medical Sciences, Lahore, Punjab, Pakistan.

Saranya Palaniswamy (S)

Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.

Khurram Shahzad (K)

Punjab Institute of Cardiology, Lahore, Punjab, Pakistan.

Lathika K Athauda (LK)

Department of Public Health, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.

Ranil Jayawardena (R)

Department of Physiology, Faculty of Medicine, University of Colombo, Colombo, Western, Sri Lanka.

Tayyaba Batool (T)

Department of Endocrinology and Metabolism, Services Institute of Medical Sciences, Lahore, Punjab, Pakistan.

Saira Burney (S)

Department of Endocrinology & Metabolism, Services Institute of Medical Sciences, Lahore, Punjab, Pakistan.

Matthew Glover (M)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK.

Vodathi Bamunuarachchi (V)

Diabetes Research Unit, Faculty of Medicine, University of Colombo, Colombo, Western, Sri Lanka.

Manju Panda (M)

Institute of Endocrinology Diabetes and Metabolism, Max Healthcare, New Delhi, Delhi, India.

Madawa Madawanarachchi (M)

Diabetes Research Unit, Faculty of Medicine, University of Colombo, Colombo, Western, Sri Lanka.

Baldeesh Rai (B)

School of Public Health, Imperial College London, London, UK.

Iqra Sattar (I)

Punjab Institute of Cardiology, Lahore, Punjab, Pakistan.

Wnurinham Silva (W)

School of Public Health, Imperial College London, London, UK.

Swati Waghdhare (S)

Institute of Endocrinology Diabetes and Metabolism, Max Healthcare, New Delhi, Delhi, India.

Marjo-Riitta Jarvelin (MR)

Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
School of Public Health, Imperial College London, London, UK.
Department of Life Sciences, College of Health and Life Sciences, Brunel University, London, UK.
Unit of Primary Care, Oulu University Hospital, Oulu, Finland.

Ravindra Prasan Rannan-Eliya (RP)

Institute for Health Policy, Colombo, Sri Lanka.

Nilmini Wijemunige (N)

Institute for Health Policy, Colombo, Sri Lanka.

Heather M Gage (HM)

Surrey Health Economics Centre, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, UK.

Jonathan Valabhji (J)

Department of Diabetes and Endocrinology, Imperial College London, London, UK.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Gary S Frost (GS)

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Rajitha Wickremasinghe (R)

Department of Public Health, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.

Anuradhani Kasturiratne (A)

Department of Public Health, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.

Khadija I Khawaja (KI)

Department of Endocrinology & Metabolism, Services Institute of Medical Sciences, Lahore, Punjab, Pakistan.

Sajjad Ahmad (S)

Punjab Institute of Cardiology, Lahore, Punjab, Pakistan.

Irene Gm van Valkengoed (IG)

Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.

Prasad Katulanda (P)

Department of Clinical Medicine, University of Colombo, Colombo, Sri Lanka.

Sujeet Jha (S)

Institute of Endocrinology Diabetes and Metabolism, Max Healthcare, New Delhi, Delhi, India.

Jaspal S Kooner (JS)

London North West University Healthcare NHS Trust, Harrow, London, UK.
National Heart & Lung Institute, Faculty of Medicine, Imperial College London, London, UK.

John C Chambers (JC)

Lee Kon Chian School of Medicine, Nanyang Technological University, Singapore.
Department of Epidemiology and Biostatistics, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH